Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286742004> ?p ?o ?g. }
- W4286742004 abstract "Abstract Immune checkpoint inhibitors (ICIs) targeting PD-L1 and PD-1 have improved survival in a subset of patients with advanced non-small cell lung cancer (NSCLC). However, only a minority of NSCLC patients respond to ICIs, highlighting the need for superior immunotherapy. Herein, we report on a nanoparticle-based immunotherapy termed ARAC (Antigen Release Agent and Checkpoint Inhibitor) designed to enhance the efficacy of PD-L1 inhibitor. ARAC is a nanoparticle co-delivering PLK1 inhibitor (volasertib) and PD-L1 antibody. PLK1 is a key mitotic kinase that is overexpressed in various cancers including NSCLC and drives cancer growth. Inhibition of PLK1 selectively kills cancer cells and upregulates PD-L1 expression in surviving cancer cells thereby providing opportunity for ARAC targeted delivery in a feedforward manner. ARAC reduces effective doses of volasertib and PD-L1 antibody by 5-fold in a metastatic lung tumor model (LLC-JSP) and the effect is mainly mediated by CD8+ T cells. ARAC also shows efficacy in another lung tumor model (KLN-205), which does not respond to CTLA-4 and PD-1 inhibitor combination. This study highlights a rational combination strategy to augment existing therapies by utilizing our nanoparticle platform that can load multiple cargo types at once." @default.
- W4286742004 created "2022-07-23" @default.
- W4286742004 creator A5003878610 @default.
- W4286742004 creator A5010288220 @default.
- W4286742004 creator A5013388193 @default.
- W4286742004 creator A5023105214 @default.
- W4286742004 creator A5028899187 @default.
- W4286742004 creator A5029152724 @default.
- W4286742004 creator A5031226205 @default.
- W4286742004 creator A5032485708 @default.
- W4286742004 creator A5038908810 @default.
- W4286742004 creator A5050678264 @default.
- W4286742004 creator A5056589923 @default.
- W4286742004 creator A5058185006 @default.
- W4286742004 creator A5083234239 @default.
- W4286742004 creator A5084233435 @default.
- W4286742004 creator A5087363413 @default.
- W4286742004 date "2022-07-23" @default.
- W4286742004 modified "2023-10-10" @default.
- W4286742004 title "Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment" @default.
- W4286742004 cites W1518200290 @default.
- W4286742004 cites W1834322579 @default.
- W4286742004 cites W1889335134 @default.
- W4286742004 cites W1928807762 @default.
- W4286742004 cites W1991235944 @default.
- W4286742004 cites W1996863944 @default.
- W4286742004 cites W2026274426 @default.
- W4286742004 cites W2036238945 @default.
- W4286742004 cites W2037117428 @default.
- W4286742004 cites W2040146704 @default.
- W4286742004 cites W2044626782 @default.
- W4286742004 cites W2049553585 @default.
- W4286742004 cites W2056528509 @default.
- W4286742004 cites W2076452801 @default.
- W4286742004 cites W2127019295 @default.
- W4286742004 cites W2136394786 @default.
- W4286742004 cites W2158558808 @default.
- W4286742004 cites W2175767930 @default.
- W4286742004 cites W2177804157 @default.
- W4286742004 cites W2254524854 @default.
- W4286742004 cites W2275389390 @default.
- W4286742004 cites W2292383635 @default.
- W4286742004 cites W2346025119 @default.
- W4286742004 cites W2464405525 @default.
- W4286742004 cites W2467902526 @default.
- W4286742004 cites W2527905628 @default.
- W4286742004 cites W2533688214 @default.
- W4286742004 cites W2549761003 @default.
- W4286742004 cites W2560367415 @default.
- W4286742004 cites W2580398445 @default.
- W4286742004 cites W2587333476 @default.
- W4286742004 cites W2608165987 @default.
- W4286742004 cites W2769376007 @default.
- W4286742004 cites W2784012638 @default.
- W4286742004 cites W2795043036 @default.
- W4286742004 cites W2804845336 @default.
- W4286742004 cites W2847455257 @default.
- W4286742004 cites W2890139110 @default.
- W4286742004 cites W2890262057 @default.
- W4286742004 cites W2898915459 @default.
- W4286742004 cites W2902609075 @default.
- W4286742004 cites W2918171974 @default.
- W4286742004 cites W2921653938 @default.
- W4286742004 cites W2939342954 @default.
- W4286742004 cites W2943232183 @default.
- W4286742004 cites W2975926349 @default.
- W4286742004 cites W2997724502 @default.
- W4286742004 cites W3014043586 @default.
- W4286742004 cites W3168587734 @default.
- W4286742004 cites W4210291751 @default.
- W4286742004 doi "https://doi.org/10.1038/s41467-022-31926-9" @default.
- W4286742004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35871223" @default.
- W4286742004 hasPublicationYear "2022" @default.
- W4286742004 type Work @default.
- W4286742004 citedByCount "41" @default.
- W4286742004 countsByYear W42867420042022 @default.
- W4286742004 countsByYear W42867420042023 @default.
- W4286742004 crossrefType "journal-article" @default.
- W4286742004 hasAuthorship W4286742004A5003878610 @default.
- W4286742004 hasAuthorship W4286742004A5010288220 @default.
- W4286742004 hasAuthorship W4286742004A5013388193 @default.
- W4286742004 hasAuthorship W4286742004A5023105214 @default.
- W4286742004 hasAuthorship W4286742004A5028899187 @default.
- W4286742004 hasAuthorship W4286742004A5029152724 @default.
- W4286742004 hasAuthorship W4286742004A5031226205 @default.
- W4286742004 hasAuthorship W4286742004A5032485708 @default.
- W4286742004 hasAuthorship W4286742004A5038908810 @default.
- W4286742004 hasAuthorship W4286742004A5050678264 @default.
- W4286742004 hasAuthorship W4286742004A5056589923 @default.
- W4286742004 hasAuthorship W4286742004A5058185006 @default.
- W4286742004 hasAuthorship W4286742004A5083234239 @default.
- W4286742004 hasAuthorship W4286742004A5084233435 @default.
- W4286742004 hasAuthorship W4286742004A5087363413 @default.
- W4286742004 hasBestOaLocation W42867420041 @default.
- W4286742004 hasConcept C121608353 @default.
- W4286742004 hasConcept C126322002 @default.
- W4286742004 hasConcept C143998085 @default.
- W4286742004 hasConcept C146276462 @default.
- W4286742004 hasConcept C147483822 @default.
- W4286742004 hasConcept C159654299 @default.